New: Instantly spot drawdowns, dips, insider moves, and breakout themes across Maps and Screener.

Learn More

Here's What Key Metrics Tell Us About Scotts (SMG) Q1 Earnings

By Zacks Equity Research | January 28, 2026, 9:30 AM

Scotts Miracle-Gro (SMG) reported $354.4 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 15%. EPS of -$0.77 for the same period compares to -$0.89 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $350.63 million, representing a surprise of +1.08%. The company delivered an EPS surprise of +25.68%, with the consensus EPS estimate being -$1.04.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Scotts performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Net Sales- Other: $25.9 million versus the four-analyst average estimate of $23.11 million. The reported number represents a year-over-year change of +8.8%.
  • Net Sales- U.S.Consumer: $328.5 million versus the four-analyst average estimate of $293.75 million. The reported number represents a year-over-year change of -3.6%.
  • Segment Profit (Loss) (Non-GAAP)- U.S. Consumer: $9 million versus the two-analyst average estimate of $10.02 million.
  • Segment Profit (Loss) (Non-GAAP)- Corporate: $-25.3 million compared to the $-31.21 million average estimate based on two analysts.
  • Segment Profit (Loss) (Non-GAAP)- Other: $-1.7 million compared to the $-2.08 million average estimate based on two analysts.

View all Key Company Metrics for Scotts here>>>

Shares of Scotts have returned +9.6% over the past month versus the Zacks S&P 500 composite's +0.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
The Scotts Miracle-Gro Company (SMG): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Latest News